AMS 2024

FDA Guidance for 3D Printing of Medical Devices and Eligible R&D Tax Credits

Electronics
Metal AM Markets
AMR Military

Share this Article

The exponential growth of 3D printing technology and its application across various industries has been tremendous. In the medical field specifically, 3D printing has contributed to both clinical and innovative advancements. Additive manufacturing technologies have been applied to medical equipment, prosthetics, dental products, bioprinting, and pharmaceuticals. However, before these technological advancements can be utilized for clinical applications, the FDA must first approve them. On December 4, 2017, the FDA issued a guidance to help speed up the approval process for companies making advancements such as these. Additionally, these companies may be entitled to research and development tax credits to offset the cost associated with testing, process improvement, and production.

The Research & Development Tax Credit

Enacted in 1981, the now permanent Federal Research and Development (R&D) Tax Credit allows a credit that typically ranges from 4%-7% of eligible spending for new and improved products and processes. Qualified research must meet the following four criteria:

  • Must be technological in nature
  • Must be a component of the taxpayer’s business
  • Must represent R&D in the experimental sense and generally includes all such costs related to the development or improvement of a product or process
  • Must eliminate uncertainty through a process of experimentation that considers one or more alternatives

Eligible costs include U.S. employee wages, cost of supplies consumed in the R&D process, cost of pre-production testing, US contract research expenses, and certain costs associated with developing a patent.

On December 18, 2015, President Obama signed the PATH Act, making the R&D Tax Credit permanent. Beginning in 2016, the R&D credit can be used to offset Alternative Minimum tax for companies with revenue below $50MM and for the first time, pre-profitable and pre-revenue startup businesses can utilize the credit against $250,000 per year in payroll taxes.

The Guidance

The FDA has referred to the Technical Considerations for Additive Manufactured Medical Devices as “leapfrog guidance” because it sets up the parameters that manufacturers and innovators should have prepared when submitting their innovations for FDA approval. By doing so, submissions for 3D printed products can be expedited in the FDA approval process. 3D printing of medical devices and tools has become one of the largest areas of 3D manufacturing along with having the greatest positive impact on the world. Many of the products that have already been submitted or that are going through the approval process are life-changing, primarily for the fact that 3D printing allows for customization. When a tool or device can be easily, quickly, and cost-effectively customized to a patient’s needs or body, a large portion of the time that is spent in either a clinical or surgical setting is reduced, which improves the outcome of medical treatments as well as quality of life.

Scott Gottlieb, a physician and commissioner of the FDA, has stated that in addition to the transparent process, regulations for future submissions will allow manufacturers to bring their innovations to market more efficiently. With so many transformative medical technologies in the midst of a breakthrough on the market, manufacturers needed this guidance to help them progress through the time consuming process of FDA approval faster and more easily. The guidance includes device design, software workflow, material controls, post-processing, process validation and acceptance, quality data, and device testing considerations. All expenses related to a new product or process, including testing, are R&D tax credit eligible.

Conclusion

The new guidance outlined for the consideration of new 3D printed medical devices sets up parameters and regulations for manufacturers who want to get their 3D printed products FDA approved. The faster these approvals happen, the more the medical field can advance. The guidance requires a complete product, process, and testing framework that is ideal for optimizing R&D tax credits.

Discuss this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below. 


Charles Goulding and Rafaella July of R&D Tax Savers discuss the FDA’s issued guidance on 3D printed medical devices.

 

Share this Article


Recent News

Creating the Department of Defense’s Largest 3D Printing Repository

$138M to Support Ursa Major’s 3D Printed Rocket Engines



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

$1M to Drive Metal 3D Printing Adoption in ASTRO America Project with GE, Pratt & Whitney, and Honeywell

The Applied Science & Technology Research Organization of America (ASTRO America) has partnered with Pratt & Whitney, Honeywell, and GE on a project intended to ease adoption of metal additive...

Featured

Biden Admin Announces Flurry of Reshoring Actions, Including Council on Supply Chain Resilience

Yesterday, I posted about the over $6 billion in new funding for US advanced manufacturing related to batteries and semiconductor packaging announced by the Biden administration to be awarded in...

Taking on Metallic Glasses 3D Printing with AMAZEMET’s Lukasz Zrodowski

Metallic glasses (MGs), or amorphous metals, are materials with a disordered atomic structure, unlike the ordered crystal lattice found in traditional metals. This unique structure provides them with superior strength,...

Featured

AMS Returns with New Key Speakers from the World of 3D Printing

Additive Manufacturing Strategies (AMS) 2024, set to take place from February 6-8 in New York City, is shaping up to be a key gathering for the additive manufacturing (AM) industry....